Toshiyuki Sunaya

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings

Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono et al. · Journal of Thrombosis and Thrombolysis · 2019 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting

Kensei Yamaguchi, Yoshito Komatsu, Taroh Satoh et al. · The Oncologist · 2019 · 46 citations · Full text

Medicine, Oncology, Pharmacology +14

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

Shuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki et al. · Journal of Gastroenterology · 2016 · 35 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance

Hideyuki Akaza, Mototsugu Oya, Masafumi Iijima et al. · Japanese Journal of Clinical Oncology · 2015 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS)

Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono et al. · Journal of Cardiology · 2019 · 30 citations

Pharmacy, Cardiology, Pharmacotherapy +10